Zurich Cantonal Bank
PACB icon

Zurich Cantonal Bank’s Pacific Biosciences PACB Stock Holding History

Zurich Cantonal Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,582
Closed -$25.4K – 3226
2025
Q4 		$25.4K Buy
+13,582
New +$26.1K ﹤0.01% 2460

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Zurich Cantonal Bank's PACB Position: Q2 2026 in Review

Zurich Cantonal Bank held its Pacific Biosciences (PACB) position steady in Q2 2026 at 9,146 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Zurich Cantonal Bank first reported a position in PACB in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.19M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Zurich Cantonal Bank held 9,146 shares of Pacific Biosciences worth $15.4K as of Q2 2026.
  • Zurich Cantonal Bank left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2483 holding.
  • Zurich Cantonal Bank first reported a position in Pacific Biosciences in Q4 2015 and has held it in 42 quarters since.
  • Zurich Cantonal Bank's Pacific Biosciences position peaked at $1.19M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.